LINC02004

Across TCGA pan-cancer cohorts, LINC02004 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC02004 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher LINC02004 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02004 expression acts as an unfavorable survival marker, although some lineages such as MESO and CESC show a favorable association.

PAAD, MESO, and CESC are the cancer types where LINC02004 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.484	0.730	<.001	60	view →
MESO	OS	Tertile	II,III,IV	0.552	0.293	.003	37	view →
CESC	OS	Tertile	All	0.934	0.799	<.001	32	view →
KIRP	DFS	Median	III,IV	0.175	0.785	.001	26	view →
HNSC	DFS	Tertile	All	0.576	0.204	.001	25	view →
UCEC	OS	Median	III,IV	0.676	0.472	.023	20	view →
LUAD	DFS	Quartile	All	0.874	0.682	.008	17	view →
UVM	DFS	Quartile	II,III,IV	0.362	0.744	.011	16	view →
ACC	OS	Quartile	III,IV	0.938	0.668	.024	15	view →
LGG	OS	Tertile	All	0.941	0.873	.007	13	view →
CHOL	DFS	Median	III,IV	0.127	0.647	.006	12	view →
UCS	DFS	Tertile	IV	0.981	0.529	.042	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC02004–PAAD (OS)

Open the PAAD breakdown →